𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bortezomib in combination with dexamethasone for a young multiple myeloma with t(8; 14)

✍ Scribed by Jian-yong Li; Li-xia Wang; Wen-yi Shen; Shi-feng Lu; Li-juan Chen; Hua Lu

Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
141 KB
Volume
33
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Bortezomib in combination with dexametha
Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience
✍ Weiyan Zheng; Guoqing Wei; Xiujin Ye; Jingsong He; Li Li; Wenjun Wu; Jimin Shi; πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 245 KB

## Objective: Bortezomib-dexamethasone-thalidomide has been reported to be effective in newly-diagnosed multiple myeloma (mm) with an overall response rate of 92% and a cr rate of 18% (alexanian et al, hematology 2007;12(3):235-9), but this regimen has not been tested in the chinese patients. we re

Bortezomib, thalidomide, and dexamethaso
Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma : A retrospective study
✍ Jonathan L. Kaufman; Ajay Nooka; Mark Vrana; Charise Gleason; L. Thompson Heffne πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 172 KB

## Abstract ## BACKGROUND: This single‐center retrospective study determined the efficacy of bortezomib, thalidomide, and dexamethasone (BTD) as induction for patients with multiple myeloma (MM) who were eligible for autologous stem cell transplantation (ASCT). ## METHODS: Patients with symptoma